Sphingosylphosphorylcholine Protects Heart Tissue in Mice
Author Information
Author(s): Christine Herzog, Martina Schmitz, Bodo Levkau, Ilka Herrgott, Jan Mersmann, Jan Larmann, Kai Johanning, Michael Winterhalter, Jerold Chun, Frank Ulrich Müller, Frank Echtermeyer, Reinhard Hildebrand, Gregor Theilmeier
Primary Institution: Hannover Medical School
Hypothesis
Does sphingosylphosphorylcholine (SPC) exert cardioprotective effects in a mouse model of myocardial ischemia with reperfusion?
Conclusion
SPC reduces infarct size and protects against myocardial reperfusion injury in mice.
Supporting Evidence
- SPC reduced infarct size by 23%, 36%, and 50% in a dose-dependent manner.
- SPC treatment decreased leukocyte recruitment to the infarcted area.
- SPC protected cardiomyocytes from apoptosis in vitro.
Takeaway
This study shows that a substance called sphingosylphosphorylcholine can help protect the heart from damage when blood flow is restored after being blocked.
Methodology
Mice underwent myocardial ischemia for 30 minutes followed by 24 hours of reperfusion, with SPC administered intravenously before and after ischemia.
Potential Biases
Potential bias due to nonrandomized study design and strain-specific effects.
Limitations
The study was conducted in a nonrandomized design and used specific mouse strains.
Participant Demographics
Mice were age and sex matched.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website